<?xml version="1.0" encoding="UTF-8"?>
<ref id="B113-pharmaceutics-12-00171">
 <label>113.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mishra</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Mahor</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rawat</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Gupta</surname>
    <given-names>P.N.</given-names>
   </name>
   <name>
    <surname>Dubey</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Khatri</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Vyas</surname>
    <given-names>S.P.</given-names>
   </name>
  </person-group>
  <article-title>Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles</article-title>
  <source>J. Drug Target.</source>
  <year>2006</year>
  <volume>14</volume>
  <fpage>45</fpage>
  <lpage>53</lpage>
  <pub-id pub-id-type="doi">10.1080/10611860600612953</pub-id>
  <?supplied-pmid 16603451?>
  <pub-id pub-id-type="pmid">16603451</pub-id>
 </element-citation>
</ref>
